Cost considerations of the new fixed combination for glaucoma medical therapy

• In: SIG Pharmacoeconomics/Pharmacoepidemiology - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: PP-P-024
• By: CHEN, Hsien-Li (Chang Gung Memorial Hospital, Taipei, China Taiwan)
• Co-author(s): Deng, Shin-Tarng (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
  Hsieh, Ming-Chieh (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
  Mau, Jan-Yen* (Chang Gung Memorial Hospital, TAIPEI, China Taiwan)
  
• Abstract:

  Aims: To determine the daily cost of the CosoptÂ[RSYMBOL] (Dorzolamide/Timolol), CombiganÂ[RSYMBOL] (brimonidine tartrate/timolol), and XalacomÂ[RSYMBOL] (latanoprost /timolol) for medical therapy of glaucoma.
  
  Methods: The studied drugs were: CosoptÂ[RSYMBOL] (5.0 ml/ bottle) and CombiganÂ[RSYMBOL] (5.0 ml/ bottle), and XalacomÂ[RSYMBOL]..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login